Sonix Health vs ElucidVivo A.3

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Sonix Health

by Ontact Health Co.

ElucidVivo A.3

by Elucid

AI Verdict

Sonix Health is an AI-powered solution for automating echocardiography analysis, focusing on cardiac ultrasound images to assess heart function and structure. In contrast, ElucidVivo A.3 specializes in quantitative analysis of arterial plaque composition from CT angiography for atherosclerosis patient stratification. While both are FDA-cleared AI tools enhancing cardiovascular diagnostics, they address distinct imaging modalities and specific clinical problems, making them complementary rather than direct competitors.

Choose Sonix Health if…

Choose Sonix Health if your primary need is to automate and enhance the analysis of echocardiography images. This tool is ideal for cardiologists and critical care physicians seeking to improve efficiency and diagnostic precision in assessing cardiac function through automated measurements, strain analysis, and report generation from ultrasound studies. It streamlines the workflow for interpreting echocardiograms, regardless of the ultrasound vendor.

View Sonix Health →

Choose ElucidVivo A.3 if…

Choose ElucidVivo A.3 if your focus is on detailed, quantitative analysis of arterial plaque composition from CT angiography scans. This system is best suited for cardiologists, radiologists, and vascular surgeons who need to stratify atherosclerosis patients, visualize plaque characteristics in 3D, and optimize treatment decisions based on objective measurements of lipid-rich necrotic core, matrix, and calcifications. It provides critical insights into plaque stability and cardiovascular risk beyond standard imaging.

View ElucidVivo A.3 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Sonix Health	ElucidVivo A.3
Pricing	Contact vendor for pricing.	Unknown
Deployment	Software only, installed directly on customer PC hardware; also offers cloud or on-premise options.	Cloud and on-premise secure deployment.
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Sonix Health

Sonix Health explicitly emphasizes a 'Simplicity in Experience' and user reviews confirm its intuitive interface and 'one-touch analysis' for automated echocardiography, making it highly accessible for various medical staff. Its vendor-independent technology also simplifies installation and reduces IT burden. ElucidVivo A.3, while integrated into workflows, involves more intricate analysis that may require a steeper learning curve.

Clinical Value

ElucidVivo A.3

Both tools are FDA-cleared and offer significant clinical value. However, ElucidVivo A.3 provides more profound and predictive clinical insights by quantitatively analyzing arterial plaque composition and stability, validated against histology, and deriving fractional flow reserve (FFRct). This enables advanced patient stratification and optimizes long-term treatment decisions for atherosclerosis, offering a higher level of impact on patient management.

Pricing & Value

ElucidVivo A.3

While both tools require direct vendor contact for pricing, ElucidVivo A.3 has demonstrated significant progress in securing broad reimbursement coverage from major payers, including United Healthcare and Medicare. This established reimbursement pathway provides a clearer economic value and reduces financial uncertainty for adopting healthcare institutions.

Enterprise Readiness

Sonix Health

Sonix Health explicitly states HIPAA and DICOM compliance, and offers flexible deployment options (PC, cloud, on-premise) with vendor-independent technology. Its reported use in approximately 3,000 medical institutions globally further demonstrates its proven enterprise readiness and scalability. ElucidVivo A.3 implies HIPAA compliance and integrates with PACS/EMR, but lacks the same level of explicit detail and widespread adoption figures.

Innovation

ElucidVivo A.3

ElucidVivo A.3 demonstrates greater innovation by offering quantitative analysis of arterial plaque composition and stability from CT angiography, validated against ground-truth histology, and deriving FFRct. This provides predictive insights for personalized atherosclerosis management, representing a more significant advancement in diagnostic capabilities compared to Sonix Health's automation of existing echocardiography measurements.

Support & Docs

Tie

Neither the provided structured facts nor the web searches yielded specific, comparable information regarding the level of customer support, availability of comprehensive documentation, or training resources for either Sonix Health or ElucidVivo A.3. Therefore, it is not possible to definitively pick a winner in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Sonix Health	ElucidVivo A.3
Name	Sonix Health	ElucidVivo A.3
Company	Ontact Health Co.	Elucid Bioimaging
Primary Function	AI-powered echocardiography analysis solution that automates the measurement and reporting of cardiac ultrasound images.	AI-powered medical image analysis system that provides quantitative analysis of arterial plaque composition and stability from CT angiography.
Main Clinical Focus	Echocardiography analysis (cardiac ultrasound images)	Arterial plaque composition and stability analysis (CT angiography)
Key AI Capabilities	AI-Powered Fully-Automated Echocardiography Analysis, View Recognition, Auto Measure, Auto Strain, Image Quality Meter.	AI-powered quantitative analysis of arterial plaque, objectively quantifies Lipid-Rich Necrotic Core (LRNC), matrix, and calcifications from CT images, visualizes lesion-level plaque composition, derives fractional flow reserve (FFRct).
Specialties Supported	Cardiology, Critical Care, Radiology	Cardiology, Radiology, Vascular Surgery
Vendor Independence	Vendor-independent technology	Not specified

Videos

Demos, reviews, and walkthroughs featuring Sonix Health and ElucidVivo A.3.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary difference in the type of medical imaging analysis performed by Sonix Health and ElucidVivo A.3?

Sonix Health focuses on AI-powered analysis of echocardiography (cardiac ultrasound) images, automating measurements and reporting for cardiac function. ElucidVivo A.3, conversely, provides AI-powered quantitative analysis of arterial plaque composition and stability from CT angiography images to assist in atherosclerosis patient stratification.

Which specific clinical applications or patient populations do these tools primarily target?

Sonix Health is designed to enhance efficiency and diagnostic precision for physicians analyzing general cardiac ultrasound images, applicable across various cardiac conditions. ElucidVivo A.3 specifically aids in atherosclerosis patient stratification and optimizes treatment decisions by offering detailed visualization and measurement of arterial plaque characteristics.

What are the key quantitative measurements or insights provided by each tool?

Sonix Health offers AI-powered fully-automated echocardiography analysis, including auto measure for B-mode, M-mode, and Doppler parameters, and auto strain analysis without EKG. ElucidVivo A.3 objectively quantifies Lipid-Rich Necrotic Core (LRNC), matrix, and calcifications from CT images, visualizes lesion-level plaque composition, and derives fractional flow reserve (FFRct).

How do these tools integrate into existing clinical workflows and IT infrastructure?

Sonix Health is deployed as software only, installed directly on customer PC hardware, with options for cloud or on-premise deployment, and is DICOM compliant. ElucidVivo A.3 is a software application, likely on-premise or cloud-based, and is expected to integrate with PACS/EMR systems.

What are the primary medical specialties that would benefit most from each tool?

Sonix Health is beneficial for Cardiology, Critical Care, and Radiology specialties. ElucidVivo A.3 is primarily suited for Cardiology, Radiology, and Vascular Surgery specialties, focusing on cardiovascular care related to arterial plaque.

What kind of validation or accuracy information is available for each tool's analytical capabilities?

Sonix Health features view recognition with 96.25% accuracy for 37 FDA-approved views and an AI-powered image quality meter for precision diagnostics. ElucidVivo A.3's quantitative analysis of arterial plaque composition and stability is validated against ground-truth histology.